Five Prime Therapeutics Inc Logo Image

Five Prime Therapeutics Inc

Most Recent Responsibility Report

Five Prime Therapeutics Inc

Responsibility
Report

Five Prime Therapeutics Inc does not currently have any reports on ResponsibilityReports.co.uk. Click the button below to be notified when financial info becomes available.



About Five Prime Therapeutics Inc

51-200 Employees
Based in San Francisco, California

Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ib clinical trials for the treatment of rheumatoid arthritis; and in pre-IND stage for pigmented villonodular synovitis and multiple cancers in combination with nivolumab.

Ticker:
FPRX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Responsibility Reports?

Search by company name or ticker symbol